ADARx Pharmaceuticals, Inc. (ADRX)

ADARx Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

ADARx Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	6.13	3.45	-
Revenue Growth	-	-	-
Gross Profit	6.13	3.45	-
Selling, General & Admin	-	20.3	14.88
Research & Development	-	71.51	43.36
Operating Expenses	-	91.81	58.23
Operating Income	-106.3	-88.37	-58.23
Interest Expense (Income)	-16.66	-13.64	-11.4
Other Expense (Income)	-1.78	-1.64	-0.48
Pretax Income	-87.87	-73.09	-46.36
Net Income	-87.87	-73.09	-46.36

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-90.21	259.35	-49.02
Free Cash Flow Growth	-	-	-
Gross Margin	100.00%	100.00%	-
Operating Margin	-1734.98%	-2562.05%	-
Profit Margin	-1434.14%	-2119.11%	-
Free Cash Flow Margin	-1472.37%	7519.66%	-
EBITDA	-101.88	-84.4	-56.25
EBITDA Margin	-1662.85%	-2447.14%	-
Depreciation & Amortization	2.64	2.33	1.5
EBIT	-104.53	-86.73	-57.76
EBIT Margin	-1705.97%	-2514.61%	-